NASDAQ:ESPR
$6.68
(
0.451%
)
Friday, 27th Jan 2023
Esperion Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $5.75 | $7.41 | Friday, 27th Jan 2023 ESPR stock ended at $6.68. This is 0.451% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 4.71% from a day low at $6.58 to a day high of $6.89. |
| 90 days | $4.88 | $8.87 | |
| 52 weeks | $3.28 | $8.87 |
Historical Esperion Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $6.66 | $6.89 | $6.58 | $6.68 | 954 437 |
| 2023-01-26 | $6.77 | $6.90 | $6.56 | $6.65 | 982 817 |
| 2023-01-25 | $6.65 | $6.71 | $6.50 | $6.69 | 1 207 796 |
| 2023-01-24 | $6.69 | $7.04 | $6.64 | $6.72 | 651 094 |
| 2023-01-23 | $6.85 | $7.14 | $6.66 | $6.69 | 1 053 140 |
| 2023-01-20 | $6.85 | $6.91 | $6.65 | $6.83 | 809 425 |
| 2023-01-19 | $6.83 | $7.02 | $6.78 | $6.85 | 911 100 |
| 2023-01-18 | $6.99 | $7.06 | $6.76 | $6.81 | 1 218 011 |
| 2023-01-17 | $7.20 | $7.25 | $6.81 | $7.00 | 1 075 900 |
| 2023-01-13 | $6.96 | $7.22 | $6.89 | $7.17 | 1 341 537 |
| 2023-01-12 | $7.24 | $7.24 | $6.41 | $7.01 | 2 981 372 |
| 2023-01-11 | $7.25 | $7.35 | $7.00 | $7.30 | 1 647 200 |
| 2023-01-10 | $7.00 | $7.41 | $6.97 | $7.26 | 2 697 304 |
| 2023-01-09 | $6.27 | $7.15 | $6.27 | $6.99 | 2 896 011 |
| 2023-01-06 | $6.30 | $6.45 | $6.19 | $6.30 | 983 200 |
| 2023-01-05 | $6.01 | $6.35 | $5.96 | $6.29 | 1 391 738 |
| 2023-01-04 | $5.84 | $6.13 | $5.75 | $6.02 | 1 001 074 |
| 2023-01-03 | $6.29 | $6.41 | $5.76 | $5.84 | 1 081 631 |
| 2022-12-30 | $5.89 | $6.32 | $5.78 | $6.23 | 2 286 127 |
| 2022-12-29 | $5.93 | $6.00 | $5.78 | $5.86 | 748 678 |
| 2022-12-28 | $5.86 | $5.96 | $5.79 | $5.90 | 705 420 |
| 2022-12-27 | $6.12 | $6.12 | $5.80 | $5.87 | 1 061 598 |
| 2022-12-23 | $6.34 | $6.34 | $6.03 | $6.07 | 834 351 |
| 2022-12-22 | $6.44 | $6.75 | $6.23 | $6.36 | 1 883 051 |
| 2022-12-21 | $6.25 | $6.61 | $6.19 | $6.44 | 1 675 396 |
| 2022-12-20 | $5.80 | $6.29 | $5.73 | $6.24 | 1 615 915 |
| 2022-12-19 | $6.14 | $6.33 | $5.72 | $5.90 | 1 917 018 |
| 2022-12-16 | $5.95 | $6.23 | $5.75 | $6.14 | 3 198 205 |
| 2022-12-15 | $5.83 | $6.05 | $5.67 | $5.85 | 2 813 414 |
| 2022-12-14 | $5.58 | $5.87 | $5.51 | $5.82 | 2 180 270 |
| 2022-12-13 | $5.46 | $5.70 | $5.15 | $5.60 | 2 434 615 |
| 2022-12-12 | $5.05 | $5.62 | $4.88 | $5.37 | 4 631 331 |
| 2022-12-09 | $6.07 | $6.14 | $5.04 | $5.09 | 7 072 660 |
| 2022-12-08 | $6.26 | $6.78 | $5.92 | $6.18 | 4 787 492 |
| 2022-12-07 | $8.35 | $8.87 | $6.13 | $6.33 | 23 132 171 |
| 2022-12-06 | $7.41 | $7.47 | $7.28 | $7.44 | 988 074 |
| 2022-12-05 | $7.39 | $7.50 | $7.22 | $7.49 | 608 640 |
| 2022-12-02 | $6.90 | $7.39 | $6.90 | $7.39 | 708 120 |
| 2022-12-01 | $6.70 | $7.14 | $6.66 | $6.94 | 1 061 043 |
| 2022-11-30 | $6.58 | $6.81 | $6.56 | $6.70 | 1 746 330 |
| 2022-11-29 | $6.60 | $6.72 | $6.50 | $6.54 | 1 042 222 |
| 2022-11-28 | $6.87 | $7.02 | $6.56 | $6.59 | 846 122 |
| 2022-11-25 | $6.73 | $6.88 | $6.60 | $6.86 | 523 501 |
| 2022-11-23 | $6.96 | $7.08 | $6.73 | $6.75 | 1 092 848 |
| 2022-11-22 | $6.69 | $7.10 | $6.52 | $6.99 | 1 434 602 |
| 2022-11-21 | $7.16 | $7.18 | $6.63 | $6.65 | 1 244 271 |
| 2022-11-18 | $7.08 | $7.48 | $6.93 | $7.22 | 745 821 |
| 2022-11-17 | $7.27 | $7.32 | $7.03 | $7.06 | 560 673 |
| 2022-11-16 | $7.30 | $7.58 | $7.26 | $7.30 | 988 370 |
| 2022-11-15 | $7.43 | $7.51 | $7.14 | $7.24 | 724 828 |
About Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
